Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer

Journal of the Canadian Urological Association

Volumn 1, Issue 3, 2007, Pages 269-272

  Fradet, Vincent ^a   Gaudreau, Christiane ^a   Perrotte, Paul ^a   Côté, Jean ^a   Paquin, Jean Marie ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70849084046     PISSN: 19116470     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Morales A, Eidinger D, Bruce AW. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 1976;116:180.
2. Kamat AM, Lamm DL. Immunotherapy for bladder cancer. Curr Urol Rep 2001;2:62-69.
3. Lamm DL. Efficacy and safety of bacillus Calmette-Guerin immunotherapy in superficial bladder cancer. Clin Infect Dis 2000;31(Suppl. 3):86-90.
4. Lamm DL, Stogdill VD, Stogdill BJ, et al. Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer. J Urol 1986;135:272-274.
5. Debois H, Loupi E, Saliou P, et al. Evaluation de la tolerance de la BCG thérapie endovésicale en France: analyse des événements indésirables graves notifiés sur une période de trois ans. Progrès en Urol 2001;11:458-465.
6. Lamm DL, van der Meijden PM, Morales A, et al. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 1992;147:596-600.
7. Elkabani M, Greene JN, Vincent AL, et al. Disseminated Mycobacterium bovis after intravesicular bacillus Calmette-Guérin treatments for bladder cancer. Cancer Control 2000;7:476-480.
8. Aljada IS, Crane JK, Corriere N, et al. Mycobacterium bovisBCG causing vertebral osteomyelitis (Pott's Disease) following intravesical BCG therapy. J Clin Microbiol 1999; 37:2106-2108.
9. Kamphuis JT, Buiting AG, Misere JF, et al. BCG immunotherapy: be cautious of granulomas. Disseminated BCG infection and mycotic aneurysm as late complication of intravesical BCG instillations. Neth J Med 2001;58:71-75.
10. Mangiarotti B, Trinchieri A, Marconato R, et al. Skin abscess after intravesical instillation of bacillus Calmette-Guerin for prophylactic treatment of transitional cell carcinoma. J Urol 2002;168:1094-1095.
11. Göttke MU, Wong P, Muhn C, et al. Hepatitis in disseminated bacillus CalmetteGuérin infection. Can J Gastroenterol 2000;14:333-336.
12. Al-Bhlal LA. Pathologic findings for bacille Calmette-Guérin infections in immunocompetent and immunocompromised patients. Am J Clin Pathol 2000;113:703-708.
13. Saint F, Irani J, Patard JJ, et al. Tolerability of bacille Calmette-Guerin maintenance therapy for superficial bladder cancer. Urology 2001;57:883-888.
14. Saint F, Irani J, Salomon L, et al. Etude de la tolérance et de l'efficacité des instillations endovésicales de Bacille Calmette-Guérin dans le traitement prophylactique des tumeurs superficielles de vessie, en utilisant un traitement d'entretien. Progrès Urol 2001;11:647-656.
15. Vegt PDJ, van der Meijden APM, Sylvester R, et al. Does isoniazid reduce side effects of intravesical bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim Results of European Organization for Research and Treatment of Cancer Protocol 30911. J Urol 1997;157:1246-1249.
16. Durek C, Rusch-Gerdes S, Jocham D, et al. Sensitivity of BCG to modern antibiotics. Eur Urol 2000;37(Suppl 1):21-25.
17. Huang TC. Management of complications of bacillus Calmette-Guerin immunotherapy in the treatment of bladder cancer. Ann Pharmacother 2000;34: 529-532.
18. Fendler JP, Debois H, Mège JL, et al. BCGite: l'ofloxacine peut-elle constituer une alternative au traitement antituberculeux? Progrès Urol 2002;12:309-312.
19. Su WJ, Huang CY, Huang CY, et al. Utility of PCR assays for rapid diagnosis of BCG infection in children. Int J Tuberc Lung Dis 2001;5:380-384.
20. Grange JM. Complications of bacilli Calmette-Guérin (BCG) vaccine. Commun Dis Public Health 1998;1:84-88.
21. Alexandroff AB, Jackson AM, O'Donnell MA, et al. BCG immunotherapy of bladder cancer: 20 years on. Lancet 1999;353:1689-1694.
22. Durek C, Richter E, Bastek A, et al. The fate of bacillus Calmette-Guerin after intravesical instillation. J Urol 2001;165:1765-1768.